Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Granzyme B accelerates skin aging and impairs healing by breaking down important skin components.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

S100A6 protein is linked to disease progression, especially in cancers.

New inhibitors may reduce gut toxicity from cancer drugs.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

Promising cancer treatments were found, but the manufacturer closed.

Basonuclin helps keratinocytes multiply and prevents them from fully maturing.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

CRABP1 boosts hair cell growth in Hu sheep by affecting key genes.

High glycine–tyrosine keratin-associated proteins help make hair strong and maintain its shape.

Mice with human chymase had a higher death rate when exposed to a toxin compared to normal mice.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.